🟢 MetaVia is trading 6.16% up in pre-market; reason unconfirmed

MetaVia is trading at $1.55 (+6.16%), with no clear catalyst identified.

• No clear company-specific announcement or overnight catalyst was identified for August 24, 2026.
• The latest major company update was August 6, 2026, covering second-quarter results and clinical progress for DA-1726; it does not explain this morning’s move.
• Broader indexes are lower, so market sentiment does not clearly account for MetaVia’s gain. The reason remains unconfirmed pending additional filings or news.